Brightworth Sells 627 Shares of BlackRock, Inc. (BLK)

Brightworth lessened its holdings in shares of BlackRock, Inc. (NYSE:BLK) by 4.5% during the 4th quarter, according to its most recent 13F filing with …

BlackRock logoBrightworth lessened its holdings in shares of BlackRock, Inc. (NYSE:BLK) by 4.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,187 shares of the asset manager’s stock after selling 627 shares during the period. BlackRock accounts for approximately 1.2% of Brightworth’s investment portfolio, making the stock its 25th biggest holding. Brightworth’s holdings in BlackRock were worth $5,180,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Private Ocean LLC raised its holdings in BlackRock by 620.0% during the fourth quarter. Private Ocean LLC now owns 72 shares of the asset manager’s stock worth $28,000 after purchasing an additional 62 shares during the last quarter. Evolution Wealth Advisors LLC acquired a new position in BlackRock during the fourth quarter worth $33,000. Legacy Financial Advisors Inc. raised its holdings in BlackRock by 125.6% during the fourth quarter. Legacy Financial Advisors Inc. now owns 88 shares of the asset manager’s stock worth $35,000 after purchasing an additional 49 shares during the last quarter. Highwater Wealth Management LLC acquired a new position in BlackRock during the fourth quarter worth $41,000. Finally, Clean Yield Group acquired a new position in shares of BlackRock in the fourth quarter worth $59,000. 86.05% of the stock is currently owned by institutional investors.

Shares of BLK opened at $431.95 on Friday. The stock has a market capitalization of $68.12 billion, a P/E ratio of 16.04, a price-to-earnings-growth ratio of 1.62 and a beta of 1.37. BlackRock, Inc. has a one year low of $360.79 and a one year high of $578.80. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.76.

BlackRock (NYSE:BLK) last announced its quarterly earnings data on Wednesday, January 16th. The asset manager reported $6.08 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $6.35 by ($0.27). BlackRock had a net margin of 30.32% and a return on equity of 13.53%. The firm had revenue of $3.43 billion for the quarter, compared to analyst estimates of $3.47 billion. During the same quarter in the previous year, the company earned $6.24 EPS. The company’s quarterly revenue was down 8.8% compared to the same quarter last year. On average, research analysts anticipate that BlackRock, Inc. will post 26 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 21st. Stockholders of record on Wednesday, March 6th will be given a dividend of $3.30 per share. This represents a $13.20 dividend on an annualized basis and a dividend yield of 3.06%. This is a boost from BlackRock’s previous quarterly dividend of $3.13. The ex-dividend date is Tuesday, March 5th. BlackRock’s dividend payout ratio is presently 46.49%.

A number of equities analysts have recently weighed in on BLK shares. ValuEngine raised BlackRock from a “sell” rating to a “hold” rating in a report on Wednesday, October 31st. Morgan Stanley dropped their target price on BlackRock from $554.00 to $514.00 and set an “overweight” rating for the company in a research note on Wednesday, November 14th. Deutsche Bank dropped their target price on BlackRock from $458.00 to $444.00 and set a “buy” rating for the company in a research note on Friday, November 16th. Bank of America reiterated a “buy” rating and issued a $478.00 target price (down from $525.00) on shares of BlackRock in a research note on Thursday, December 6th. Finally, Citigroup dropped their target price on BlackRock from $500.00 to $450.00 and set a “buy” rating for the company in a research note on Wednesday, December 19th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have given a buy rating to the stock. BlackRock has a consensus rating of “Buy” and an average target price of $503.03.

In other BlackRock news, Chairman Laurence Fink sold 44,000 shares of the stock in a transaction on Monday, February 11th. The stock was sold at an average price of $412.75, for a total transaction of $18,161,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Gary Shedlin sold 5,400 shares of the stock in a transaction on Thursday, January 31st. The shares were sold at an average price of $410.74, for a total value of $2,217,996.00. The disclosure for this sale can be found here. Insiders have sold a total of 135,617 shares of company stock worth $56,380,301 over the last quarter. Insiders own 1.75% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Brightworth Sells 627 Shares of BlackRock, Inc. (BLK)” was posted by Fairfield Current and is the property of of Fairfield Current. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.fairfieldcurrent.com/news/2019/02/16/brightworth-sells-627-shares-of-blackrock-inc-blk.html.

About BlackRock

BlackRock, Inc is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Read More: Understanding Market Liquidity

Institutional Ownership by Quarter for BlackRock (NYSE:BLK)

Receive News & Ratings for BlackRock Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BlackRock and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Aft Forsyth & Company Inc. Reduces Position in BlackRock, Inc. (BLK)

Aft Forsyth & Company Inc. reduced its position in shares of BlackRock, Inc. (NYSE:BLK) by 11.4% during the fourth quarter, according to the company …

BlackRock logoAft Forsyth & Company Inc. reduced its position in shares of BlackRock, Inc. (NYSE:BLK) by 11.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,287 shares of the asset manager’s stock after selling 293 shares during the quarter. Aft Forsyth & Company Inc.’s holdings in BlackRock were worth $898,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Exchange Capital Management Inc. raised its stake in shares of BlackRock by 3.0% in the third quarter. Exchange Capital Management Inc. now owns 12,588 shares of the asset manager’s stock worth $5,933,000 after purchasing an additional 367 shares during the last quarter. Bristlecone Advisors LLC raised its stake in shares of BlackRock by 51.3% in the third quarter. Bristlecone Advisors LLC now owns 6,667 shares of the asset manager’s stock worth $3,142,000 after purchasing an additional 2,260 shares during the last quarter. New Potomac Partners LLC raised its stake in shares of BlackRock by 4.4% in the third quarter. New Potomac Partners LLC now owns 5,332 shares of the asset manager’s stock worth $2,513,000 after purchasing an additional 225 shares during the last quarter. First Trust Advisors LP raised its stake in shares of BlackRock by 8.4% in the third quarter. First Trust Advisors LP now owns 142,435 shares of the asset manager’s stock worth $67,134,000 after purchasing an additional 11,002 shares during the last quarter. Finally, JGP Wealth Management LLC raised its stake in shares of BlackRock by 37.0% in the fourth quarter. JGP Wealth Management LLC now owns 8,887 shares of the asset manager’s stock worth $3,491,000 after purchasing an additional 2,398 shares during the last quarter. 86.05% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director Jeff A. Smith sold 225 shares of the stock in a transaction that occurred on Friday, February 15th. The stock was sold at an average price of $431.01, for a total transaction of $96,977.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Gary Shedlin sold 5,400 shares of the stock in a transaction that occurred on Thursday, January 31st. The shares were sold at an average price of $410.74, for a total value of $2,217,996.00. The disclosure for this sale can be found here. Insiders have sold 135,617 shares of company stock valued at $56,380,301 over the last ninety days. 1.75% of the stock is currently owned by company insiders.

Several analysts have recently commented on the company. Morgan Stanley set a $515.00 price objective on BlackRock and gave the stock a “buy” rating in a research note on Friday, February 8th. Jefferies Financial Group raised BlackRock from a “hold” rating to a “buy” rating and set a $405.36 price objective for the company in a research note on Tuesday, January 29th. Credit Suisse Group reissued a “buy” rating and issued a $532.00 price objective on shares of BlackRock in a research note on Thursday, January 17th. Argus reissued a “buy” rating on shares of BlackRock in a research note on Thursday, January 17th. Finally, Wells Fargo & Co reissued a “hold” rating and issued a $425.00 price objective (up from $410.00) on shares of BlackRock in a research note on Wednesday, January 16th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $503.03.

Shares of BLK opened at $431.95 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.07 and a quick ratio of 3.07. The company has a market cap of $67.41 billion, a P/E ratio of 16.04, a price-to-earnings-growth ratio of 1.62 and a beta of 1.37. BlackRock, Inc. has a 12 month low of $360.79 and a 12 month high of $578.80.

BlackRock (NYSE:BLK) last issued its quarterly earnings results on Wednesday, January 16th. The asset manager reported $6.08 EPS for the quarter, missing the Zacks’ consensus estimate of $6.35 by ($0.27). The business had revenue of $3.43 billion for the quarter, compared to analysts’ expectations of $3.47 billion. BlackRock had a net margin of 30.32% and a return on equity of 13.53%. The business’s revenue was down 8.8% compared to the same quarter last year. During the same period in the previous year, the business posted $6.24 earnings per share. On average, equities research analysts predict that BlackRock, Inc. will post 26 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 21st. Investors of record on Wednesday, March 6th will be given a dividend of $3.30 per share. This represents a $13.20 dividend on an annualized basis and a dividend yield of 3.06%. This is an increase from BlackRock’s previous quarterly dividend of $3.13. The ex-dividend date of this dividend is Tuesday, March 5th. BlackRock’s dividend payout ratio (DPR) is presently 46.49%.

TRADEMARK VIOLATION WARNING: This story was posted by Fairfield Current and is owned by of Fairfield Current. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.fairfieldcurrent.com/news/2019/02/16/aft-forsyth-company-inc-reduces-position-in-blackrock-inc-blk.html.

About BlackRock

BlackRock, Inc is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Recommended Story: How Investors Use a Balance Sheet

Want to see what other hedge funds are holding BLK?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock, Inc. (NYSE:BLK).

Institutional Ownership by Quarter for BlackRock (NYSE:BLK)

Receive News & Ratings for BlackRock Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BlackRock and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Insider Selling: BlackRock, Inc. (BLK) CFO Sells 5400 Shares of Stock

BlackRock, Inc. (NYSE:BLK) CFO Gary Shedlin sold 5,400 shares of BlackRock stock in a transaction dated Thursday, January 31st. The shares were …

BlackRock logoBlackRock, Inc. (NYSE:BLK) CFO Gary Shedlin sold 5,400 shares of BlackRock stock in a transaction dated Thursday, January 31st. The shares were sold at an average price of $410.74, for a total transaction of $2,217,996.00. The sale was disclosed in a document filed with the SEC, which is available at this link.

Gary Shedlin also recently made the following trade(s):

  • On Tuesday, January 29th, Gary Shedlin sold 1,000 shares of BlackRock stock. The shares were sold at an average price of $410.00, for a total transaction of $410,000.00.

Shares of BLK stock opened at $431.95 on Friday. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.76. BlackRock, Inc. has a 12-month low of $360.79 and a 12-month high of $578.80. The firm has a market cap of $68.12 billion, a PE ratio of 16.04, a P/E/G ratio of 1.62 and a beta of 1.37.

BlackRock (NYSE:BLK) last issued its quarterly earnings data on Wednesday, January 16th. The asset manager reported $6.08 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $6.35 by ($0.27). BlackRock had a return on equity of 13.53% and a net margin of 30.32%. The company had revenue of $3.43 billion for the quarter, compared to the consensus estimate of $3.47 billion. During the same period in the prior year, the company earned $6.24 EPS. The firm’s revenue was down 8.8% on a year-over-year basis. On average, research analysts anticipate that BlackRock, Inc. will post 26 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 21st. Investors of record on Wednesday, March 6th will be issued a dividend of $3.30 per share. This is a boost from BlackRock’s previous quarterly dividend of $3.13. The ex-dividend date is Tuesday, March 5th. This represents a $13.20 annualized dividend and a yield of 3.06%. BlackRock’s dividend payout ratio is presently 46.49%.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Capital World Investors lifted its stake in BlackRock by 1.8% in the third quarter. Capital World Investors now owns 8,353,670 shares of the asset manager’s stock valued at $3,937,335,000 after acquiring an additional 148,805 shares during the last quarter. Northern Trust Corp increased its position in BlackRock by 0.9% during the fourth quarter. Northern Trust Corp now owns 1,666,574 shares of the asset manager’s stock worth $654,663,000 after acquiring an additional 14,587 shares during the period. Geode Capital Management LLC increased its holdings in BlackRock by 4.4% in the 4th quarter. Geode Capital Management LLC now owns 1,443,990 shares of the asset manager’s stock valued at $566,150,000 after buying an additional 60,941 shares during the period. Rehmann Capital Advisory Group increased its holdings in BlackRock by 51,763.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 1,084,461 shares of the asset manager’s stock valued at $2,300,000 after buying an additional 1,082,370 shares during the period. Finally, Capital International Investors bought a new position in BlackRock in the 3rd quarter valued at about $477,939,000. Institutional investors and hedge funds own 86.05% of the company’s stock.

A number of equities analysts have commented on the stock. Zacks Investment Research lowered shares of BlackRock from a “hold” rating to a “sell” rating in a research report on Tuesday, January 8th. Morgan Stanley set a $515.00 target price on shares of BlackRock and gave the stock a “buy” rating in a research report on Friday, February 8th. Barclays reiterated a “buy” rating on shares of BlackRock in a research report on Thursday, January 10th. Keefe, Bruyette & Woods reissued a “buy” rating and set a $472.00 price target on shares of BlackRock in a research note on Wednesday, January 9th. Finally, ValuEngine raised shares of BlackRock from a “sell” rating to a “hold” rating in a research note on Wednesday, October 31st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. BlackRock currently has an average rating of “Buy” and a consensus target price of $503.03.

WARNING: This piece of content was originally published by Fairfield Current and is the sole property of of Fairfield Current. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.fairfieldcurrent.com/news/2019/02/16/blackrock-inc-blk-cfo-gary-shedlin-sells-5400-shares-of-stock.html.

BlackRock Company Profile

BlackRock, Inc is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Featured Story: Ex-Dividend

Insider Buying and Selling by Quarter for BlackRock (NYSE:BLK)

Receive News & Ratings for BlackRock Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BlackRock and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

iShares MSCI Kokusai ETF (NYSEARCA:TOK) Shares Bought by BlackRock Inc.

BlackRock Inc. lifted its position in iShares MSCI Kokusai ETF (NYSEARCA:TOK) by 86.1% in the 3rd quarter, according to the company in its most …

iShares MSCI Kokusai ETF logoBlackRock Inc. lifted its position in iShares MSCI Kokusai ETF (NYSEARCA:TOK) by 86.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 39,738 shares of the company’s stock after purchasing an additional 18,389 shares during the quarter. BlackRock Inc. owned about 1.73% of iShares MSCI Kokusai ETF worth $2,690,000 as of its most recent SEC filing.

Separately, Mitsubishi UFJ Asset Management UK Ltd. acquired a new stake in shares of iShares MSCI Kokusai ETF in the 3rd quarter valued at approximately $762,049,000.

iShares MSCI Kokusai ETF stock opened at $64.32 on Friday. iShares MSCI Kokusai ETF has a fifty-two week low of $55.16 and a fifty-two week high of $68.68.

ILLEGAL ACTIVITY WARNING: This news story was published by Fairfield Current and is the sole property of of Fairfield Current. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.fairfieldcurrent.com/news/2019/02/16/blackrock-inc-grows-position-in-ishares-msci-kokusai-etf-tok.html.

Featured Article: How To Calculate Debt-to-Equity Ratio

Institutional Ownership by Quarter for iShares MSCI Kokusai ETF (NYSEARCA:TOK)

Receive News & Ratings for iShares MSCI Kokusai ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iShares MSCI Kokusai ETF and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

BlackRock Inc. Increases Stake in AcelRx Pharmaceuticals Inc (ACRX)

BlackRock Inc. lifted its stake in shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) by 16.8% in the 3rd quarter, according to its most recent Form …

AcelRx Pharmaceuticals logoBlackRock Inc. lifted its stake in shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) by 16.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 786,034 shares of the specialty pharmaceutical company’s stock after purchasing an additional 112,919 shares during the quarter. BlackRock Inc. owned about 1.27% of AcelRx Pharmaceuticals worth $3,026,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the company. FMR LLC grew its position in shares of AcelRx Pharmaceuticals by 1,094.6% during the 2nd quarter. FMR LLC now owns 298,644 shares of the specialty pharmaceutical company’s stock valued at $1,008,000 after acquiring an additional 273,644 shares during the period. Renaissance Technologies LLC bought a new position in AcelRx Pharmaceuticals in the 2nd quarter worth approximately $1,676,000. Creative Planning boosted its holdings in AcelRx Pharmaceuticals by 256.1% in the 3rd quarter. Creative Planning now owns 45,222 shares of the specialty pharmaceutical company’s stock worth $174,000 after buying an additional 32,522 shares during the period. Cedar Wealth Management LLC boosted its holdings in AcelRx Pharmaceuticals by 182.5% in the 3rd quarter. Cedar Wealth Management LLC now owns 33,895 shares of the specialty pharmaceutical company’s stock worth $130,000 after buying an additional 21,895 shares during the period. Finally, Fosun International Ltd bought a new position in AcelRx Pharmaceuticals in the 3rd quarter worth approximately $1,940,000. Institutional investors and hedge funds own 10.79% of the company’s stock.

Shares of NASDAQ:ACRX opened at $2.90 on Friday. AcelRx Pharmaceuticals Inc has a one year low of $1.65 and a one year high of $5.05. The firm has a market capitalization of $179.53 million, a price-to-earnings ratio of -2.64 and a beta of 1.99.

In other news, CEO Vincent J. Angotti purchased 10,000 shares of the business’s stock in a transaction on Wednesday, December 12th. The stock was purchased at an average cost of $2.99 per share, with a total value of $29,900.00. Following the acquisition, the chief executive officer now directly owns 51,040 shares in the company, valued at $152,609.60. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Pamela P. Palmer purchased 16,000 shares of the business’s stock in a transaction on Monday, November 19th. The stock was purchased at an average cost of $3.07 per share, with a total value of $49,120.00. Following the completion of the acquisition, the insider now owns 472,134 shares in the company, valued at $1,449,451.38. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 34,610 shares of company stock valued at $102,956. Insiders own 25.50% of the company’s stock.

Several research analysts recently commented on the stock. Credit Suisse Group assumed coverage on shares of AcelRx Pharmaceuticals in a report on Friday. They issued an “outperform” rating and a $7.00 price objective for the company. HC Wainwright reaffirmed a “buy” rating and issued a $9.00 price objective on shares of AcelRx Pharmaceuticals in a report on Wednesday, December 12th. Cantor Fitzgerald set a $8.00 price objective on shares of AcelRx Pharmaceuticals and gave the stock a “buy” rating in a report on Thursday, October 25th. Royal Bank of Canada set a $7.00 price objective on shares of AcelRx Pharmaceuticals and gave the stock a “buy” rating in a report on Monday, October 22nd. Finally, Zacks Investment Research raised shares of AcelRx Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Monday, November 19th. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $7.78.

WARNING: “BlackRock Inc. Increases Stake in AcelRx Pharmaceuticals Inc (ACRX)” was posted by Fairfield Current and is the property of of Fairfield Current. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://www.fairfieldcurrent.com/news/2019/02/16/blackrock-inc-has-3-03-million-position-in-acelrx-pharmaceuticals-inc-acrx.html.

AcelRx Pharmaceuticals Company Profile

AcelRx Pharmaceuticals, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain.

See Also: What is the Stochastic Momentum Index (SMI)?

Institutional Ownership by Quarter for AcelRx Pharmaceuticals (NASDAQ:ACRX)

Receive News & Ratings for AcelRx Pharmaceuticals Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AcelRx Pharmaceuticals and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts